In this article (Clin Cancer Res 2015;21:201–10), which was published in the January 1, 2015, issue of Clinical Cancer Research (1), the grant support is listed incorrectly. It should read as follows: “This work was supported by research grants from the National Science Council, Taiwan (NSC99-2628-B-038-009-MY3, NSC(100-102)-2321-B-038-003, NSC102-2628-B-038-008-MY3, and NSC101-2314-B-182A-028), Ministry of Science and Technology, Taiwan (MOST 103-2321-B-038-011), Health and Welfare Surcharge of Tobacco Products (MOHW103-TD-B-111-01), Chang Gung Memorial Hospital (CMRPG680311, CMRPG690411, CMRPG6A0471, CMRPG6B0381, CMRPG6C0061, CMRPG6C0062, and CMRPG6C0063), Taipei Medical University (TMUTOP103002-9).” The authors regret this error.

1.
Chang
T-S
,
Yu
Y-C
,
Chi
C-C
,
Su
W-C
,
Chang
P-J
,
Lee
K-F
, et al
Activation of IL6/IGFIR confers poor prognosis of HBV-related hepatocellular carcinoma through induction of OCT4/NANOG expression
.
Clin Cancer Res
2015
;
21
:
201
10
.